Galectin Therapeutics
GALT
#7643
Rank
NZ$0.65 B
Marketcap
NZ$10.08
Share price
6.83%
Change (1 day)
203.11%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2025 (TTM): NZ-$1.07

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$1.12. In 2024 the company made an earnings per share (EPS) of NZ-$1.31 a decrease over its 2023 EPS that were of NZ-$1.27.

EPS history for Galectin Therapeutics from 2001 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$1.07-17.87%
2024NZ-$1.312.7%
2023NZ-$1.2713.85%
2022NZ-$1.1225%
2021NZ-$0.8926.83%
2020NZ-$0.705.13%
2019NZ-$0.672.63%
2018NZ-$0.65-22.45%
2017NZ-$0.84-35.53%
2016NZ-$1.31-13.64%
2015NZ-$1.5112.82%
2014NZ-$1.34-40%
2013NZ-$2.2380.56%
2012NZ-$1.24-32.08%
2011NZ-$1.8213.98%
2010NZ-$1.60-22.5%
2009NZ-$2.06185.71%
2008NZ-$0.72-70.83%
2007NZ-$2.48118.18%
2006NZ-$1.13-54.17%
2005NZ-$2.48-14.29%
2004NZ-$2.8947.37%
2003NZ-$1.96-13.64%
2002NZ-$2.27-24.14%
2001NZ-$2.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
NZ-$21.01 1,780.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.17-115.38%๐Ÿ‡บ๐Ÿ‡ธ USA